Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs MRNA✓SelectedUSD · MRNAWMB vs MRNA performance historyLatest closeAs of-0.22%11/17
Stock and ETF performance explorer

WMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+321.3%
MRNA return
+840.0%
Excess return
-518.7%
Maximum drawdown
-66.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.2%-3.9%+3.7%-0.2%
7D0.0%-17.6%+17.6%-0.1%
30D-5.4%-5.1%-0.2%-5.4%
3M-7.5%+220.8%-228.3%-6.8%
6M-11.9%+321.7%-333.6%-11.4%
YTD+14.7%+601.3%-586.6%+14.8%
1Y+16.0%+735.2%-719.2%+15.9%
3Y+113.0%+170.5%-57.5%+113.5%
5Y+197.9%-14.6%+212.5%+197.3%
All+321.3%+840.0%-518.7%+354.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling